Enanta Pharmaceuticals financial statements

에난타 파머슈티컬스NASDAQ:ENTA · Nasdaq · Healthcare · sector #13
$12.60-2.78%
2026-10-05 close

Enanta Pharmaceuticals's published financial data is dated 2026-10-04. 2025 revenue was $65M. 2025 operating profit was −$85M.

Reported results

Enanta Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q